EGFR and lip and oral cavity carcinoma: Scheff and colleagues demonstrated that the supernatant of some oral cancer cell lines is sufficient to induce nociceptive behavior in mice, which was attenuated by EGFR inhibition, and that this supernatant contained higher levels of ADAM17 than non-nociceptive cell lines.